000 | 01840 a2200529 4500 | ||
---|---|---|---|
005 | 20250515004128.0 | ||
264 | 0 | _c20060126 | |
008 | 200601s 0 0 eng d | ||
022 | _a0002-9440 | ||
024 | 7 |
_a10.1016/S0002-9440(10)61220-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Chuan-Qing | |
245 | 0 | 0 |
_aMorphine withdrawal enhances hepatitis C virus replicon expression. _h[electronic resource] |
260 |
_bThe American journal of pathology _cNov 2005 |
||
300 |
_a1333-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 |
_aHepacivirus _xgenetics |
650 | 0 | 4 |
_aHepatitis C _xvirology |
650 | 0 | 4 |
_aHepatocytes _xvirology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon Regulatory Factor-7 _xbiosynthesis |
650 | 0 | 4 |
_aInterferon Type I _xpharmacology |
650 | 0 | 4 |
_aInterferon-alpha _xbiosynthesis |
650 | 0 | 4 |
_aMorphine _xadverse effects |
650 | 0 | 4 |
_aMorphine Dependence _xcomplications |
650 | 0 | 4 |
_aNaloxone _xpharmacology |
650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 |
_aRNA, Viral _xbiosynthesis |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 | _aReplicon |
650 | 0 | 4 | _aSubstance Withdrawal Syndrome |
650 | 0 | 4 |
_aViral Proteins _xbiosynthesis |
650 | 0 | 4 | _aVirus Replication |
700 | 1 | _aLi, Yuan | |
700 | 1 | _aDouglas, Steven D | |
700 | 1 | _aWang, Xu | |
700 | 1 | _aMetzger, David S | |
700 | 1 | _aZhang, Ting | |
700 | 1 | _aHo, Wen-Zhe | |
773 | 0 |
_tThe American journal of pathology _gvol. 167 _gno. 5 _gp. 1333-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0002-9440(10)61220-5 _zAvailable from publisher's website |
999 |
_c15878720 _d15878720 |